Investors value AI-powered consumer health tech that turns biometric data into actionable guidance, but proprietary data and proven outcomes will set rivals apart.
Premium ice cream products were a bright spot in falling US ice cream sales—wellness-centric consumers are still willing to spend on higher-quality treats.
Their melanoma trial results could pave the way for treatments that are tailored to individual patients’ tumors.
Whoop will offer advanced lab testing to more non-members, risking a low-margin standalone business if they don’t convert to wearable customers.
How weight loss brands get rated on quality, price, and customer experience is ultimately what could win patients over.
It’s testing whether its brand will be a reliable enough selling point in a sea of senior-focused insurance options.
Protein-focused RXBAR and Quest top their category in EMARKETER’s inaugural US Food and Beverage AI Visibility Index, giving them an edge over general nutrition brands in a high-demand category.
A new AI-assisted tool tracks insulin resistance trends, giving users another way to monitor metabolic health.
Women rely on peer conversations for health guidance—public forums like Reddit give marketers insight into health information gaps.
The drugmaker is also widening the crackdown by calling on social platforms and other digital players to help stop illegal sales.
Zocdoc’s new Gemini integration lets users find and schedule care in one place, turning genAI into a patient acquisition channel.
Snap wants pharma’s ad dollars, with a new format that keeps Rx ads cleaner and compliant, though potential FDA disclosure changes could undercut its value.
Cancer patients turn to peers for practical tips and clinicians for treatment decisions, creating an opportunity for pharma brands to partner with creators and advocacy groups to complement clinical guidance.
AI tools built by healthcare providers must capitalize on their trust edge over general-purpose chatbots to drive adoption.
The executive order also targets combined MMR shots, widening the divide between federal policy and medical guidance.
A new FDA proposal would require food brands to defend ingredients “generally recognized as safe” and make nutrition info more publicly available.
Novo Nordisk adds AWS to its AI roster. Deep-pocketed drugmakers can test multiple AI partners, an advantage smaller rivals may lack.
Taylor Farms’ recall reaches major grocers, widening the potential fallout from the recent produce scare.
In today’s podcast episode, we discuss what’s driving the current surge in interest in health wearables, which wearable health metrics are reliable enough for clinical decision-making, the leading devices on the market, and how AI is helping transform them into comprehensive digital health hubs. Join Senior Director of Podcasts and host Marcus Johnson, along with Senior Analysts Rajiv Leventhal and Beth Snyder Bulik, as they explore these topics. Listen wherever you get your podcasts, or watch on YouTube or Spotify.
Generic “AI-generated” tags aren’t enough to help TikTok users spot deepfake doctors or fabricated medical claims.